CRL
Price
$185.77
Change
+$3.62 (+1.99%)
Updated
Dec 20, 04:59 PM (EDT)
52 days until earnings call
MEDP
Price
$337.57
Change
+$2.42 (+0.72%)
Updated
Dec 20, 04:59 PM (EDT)
57 days until earnings call
Ad is loading...

CRL vs MEDP

Header iconCRL vs MEDP Comparison
Open Charts CRL vs MEDPBanner chart's image
Charles River Laboratories International
Price$185.77
Change+$3.62 (+1.99%)
Volume$5.04K
CapitalizationN/A
Medpace Holdings
Price$337.57
Change+$2.42 (+0.72%)
Volume$4.09K
CapitalizationN/A
CRL vs MEDP Comparison Chart
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. MEDP commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and MEDP is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (CRL: $185.77 vs. MEDP: $337.28)
Brand notoriety: CRL and MEDP are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 159% vs. MEDP: 184%
Market capitalization -- CRL: $13.96B vs. MEDP: $12.43B
CRL [@Medical Specialties] is valued at $13.96B. MEDP’s [@Medical Specialties] market capitalization is $12.43B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 0 FA rating(s) are green whileMEDP’s FA Score has 2 green FA rating(s).

  • CRL’s FA Score: 0 green, 5 red.
  • MEDP’s FA Score: 2 green, 3 red.
According to our system of comparison, MEDP is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 3 TA indicator(s) are bullish while MEDP’s TA Score has 4 bullish TA indicator(s).

  • CRL’s TA Score: 3 bullish, 6 bearish.
  • MEDP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MEDP is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а -2.46% price change this week, while MEDP (@Medical Specialties) price change was -2.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +1.84%, and the average quarterly price growth was +2.97%.

Reported Earning Dates

CRL is expected to report earnings on Feb 12, 2025.

MEDP is expected to report earnings on Feb 17, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than MEDP($12.4B). MEDP has higher P/E ratio than CRL: MEDP (44.82) vs CRL (29.15). MEDP YTD gains are higher at: 10.032 vs. CRL (-21.417). CRL has higher annual earnings (EBITDA): 1.03B vs. MEDP (363M). CRL has more cash in the bank: 277M vs. MEDP (245M). MEDP has less debt than CRL: MEDP (142M) vs CRL (3.07B). CRL has higher revenues than MEDP: CRL (4.13B) vs MEDP (1.89B).
CRLMEDPCRL / MEDP
Capitalization14B12.4B113%
EBITDA1.03B363M284%
Gain YTD-21.41710.032-213%
P/E Ratio29.1544.8265%
Revenue4.13B1.89B219%
Total Cash277M245M113%
Total Debt3.07B142M2,159%
FUNDAMENTALS RATINGS
CRL vs MEDP: Fundamental Ratings
CRL
MEDP
OUTLOOK RATING
1..100
7088
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
8216
SMR RATING
1..100
5819
PRICE GROWTH RATING
1..100
6257
P/E GROWTH RATING
1..100
5987
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRL's Valuation (77) in the Miscellaneous Commercial Services industry is in the same range as MEDP (77). This means that CRL’s stock grew similarly to MEDP’s over the last 12 months.

MEDP's Profit vs Risk Rating (16) in the Miscellaneous Commercial Services industry is significantly better than the same rating for CRL (82). This means that MEDP’s stock grew significantly faster than CRL’s over the last 12 months.

MEDP's SMR Rating (19) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for CRL (58). This means that MEDP’s stock grew somewhat faster than CRL’s over the last 12 months.

MEDP's Price Growth Rating (57) in the Miscellaneous Commercial Services industry is in the same range as CRL (62). This means that MEDP’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (59) in the Miscellaneous Commercial Services industry is in the same range as MEDP (87). This means that CRL’s stock grew similarly to MEDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLMEDP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 14 days ago
72%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 5 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
View a ticker or compare two or three
Ad is loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X97224.730000-531.203100
-0.54%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+1.99%
IQV - CRL
73%
Closely correlated
+3.00%
CTKB - CRL
61%
Loosely correlated
+2.10%
ICLR - CRL
58%
Loosely correlated
+1.42%
MEDP - CRL
56%
Loosely correlated
+0.64%
AZTA - CRL
54%
Loosely correlated
+1.88%
More

MEDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEDP has been loosely correlated with CRL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDP jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDP
1D Price
Change %
MEDP100%
+0.64%
CRL - MEDP
56%
Loosely correlated
+1.99%
IQV - MEDP
55%
Loosely correlated
+3.00%
ICLR - MEDP
40%
Loosely correlated
+1.42%
WAT - MEDP
34%
Loosely correlated
+2.09%
BIO - MEDP
31%
Poorly correlated
+0.47%
More